Estrella Cash Per Share from 2010 to 2025

ESLAW Stock   0.09  0.01  7.71%   
Estrella Immunopharma Cash Per Share yearly trend continues to be fairly stable with very little volatility. Cash Per Share will likely drop to 0.01 in 2025. During the period from 2010 to 2025, Estrella Immunopharma Cash Per Share regression line of quarterly data had mean square error of  0.04 and geometric mean of  0.26. View All Fundamentals
 
Cash Per Share  
First Reported
2010-12-31
Previous Quarter
0.0070801
Current Value
0.006726
Quarterly Volatility
0.29803308
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Estrella Immunopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Estrella Immunopharma's main balance sheet or income statement drivers, such as Tax Provision of 2 K, Depreciation And Amortization of 246.2 K or Selling General Administrative of 3.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 8.81. Estrella financial statements analysis is a perfect complement when working with Estrella Immunopharma Valuation or Volatility modules.
  
Check out the analysis of Estrella Immunopharma Correlation against competitors.
For more information on how to buy Estrella Stock please use our How to Invest in Estrella Immunopharma guide.

Latest Estrella Immunopharma's Cash Per Share Growth Pattern

Below is the plot of the Cash Per Share of Estrella Immunopharma over the last few years. It is Estrella Immunopharma's Cash Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Estrella Immunopharma's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.00 X10 Years Trend
Slightly volatile
   Cash Per Share   
       Timeline  

Estrella Cash Per Share Regression Statistics

Arithmetic Mean0.53
Geometric Mean0.26
Coefficient Of Variation55.93
Mean Deviation0.25
Median0.70
Standard Deviation0.30
Sample Variance0.09
Range0.6922
R-Value(0.75)
Mean Square Error0.04
R-Squared0.56
Significance0.0008
Slope(0.05)
Total Sum of Squares1.33

Estrella Cash Per Share History

2025 0.006726
2023 0.12
2022 0.00708

About Estrella Immunopharma Financial Statements

Estrella Immunopharma investors use historical fundamental indicators, such as Estrella Immunopharma's Cash Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Estrella Immunopharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash Per Share 0.01  0.01 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Estrella Stock Analysis

When running Estrella Immunopharma's price analysis, check to measure Estrella Immunopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Estrella Immunopharma is operating at the current time. Most of Estrella Immunopharma's value examination focuses on studying past and present price action to predict the probability of Estrella Immunopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Estrella Immunopharma's price. Additionally, you may evaluate how the addition of Estrella Immunopharma to your portfolios can decrease your overall portfolio volatility.